OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
0.01998
29.36%
0.07 / 0.078 (70000 x 10000)
Stresemannallee 4b
Neuss 41460
Germany
Stresemannallee 4b
Neuss 41460
Germany
Mr. Fahrhoefer, born in 1970, is an expert in the field of pharmaceutical wholesaling and business development in the health care industry. After studying medicine and pharmacy since 2000 he obtained his diploma as a state-certified pharmaceutical sales representative. He was working for several years in the management of various German companies. In 2001 he joined Pfizer Germany and started his career in the pharmaceutical business. He was with Pfizer Germany from 2001 to 2003 before joining Sanochemia AG in 2004 in the global management of the Diagnostics business unit. In 2009 he founded CS Diagnostics in Germany which over the years has grown into the CS Diagnostics Group which includes CS Diagnostics Pharma GmbH, CS Interpharm LLC and CS Diagnostics Corp.
Sabrina Godehardt, born on March 16, 1980 in Bad Langensalza, Germany is a certified office communication clerk with over 15 years of experience in medical administration and practice management. She worked as practice manager in a radiology and nuclear medicine clinic from 2015 to 2024, with additional responsibility for IT systems. Since June 2024, she serves as Head of Sales Coordination at CS Diagnostics Pharma GmbH. She holds IHK certifications in practice and marketing management and is proficient in MS Office, Lexware, PACS/RIS systems, and various administrative tools.
With over 22 years of professional experience in finance and banking as well as in management positions, Mohammad EsSayed has all the qualifications that FZRO needs for the tasks ahead. Mohammad EsSayed has degrees in finance, including an MBA (Master of Business Administration) in International Corporate Banking, an MFP (Master Financial Professional) and CFA (Certified Financial Analyst) from the USA. FZRO will benefit from his many years of experience as CFO and Managing Director.
Mr. Fahrhoefer, born in 1970, is an expert in the field of pharmaceutical wholesaling and business development in the health care industry. After studying medicine and pharmacy since 2000 he obtained his diploma as a state-certified pharmaceutical sales representative. He was working for several years in the management of various German companies. In 2001 he joined Pfizer Germany and started his career in the pharmaceutical business. He was with Pfizer Germany from 2001 to 2003 before joining Sanochemia AG in 2004 in the global management of the Diagnostics business unit. In 2009 he founded CS Diagnostics in Germany which over the years has grown into the CS Diagnostics Group which includes CS Diagnostics Pharma GmbH, CS Interpharm LLC and CS Diagnostics Corp.
Mahmoud A. Al-Sayyed is a senior executive with 29+ years of intensive experience in senior management and advisory positions such in (1) Investment Advisory: IPO, Mergers and Acquisitions, Business Valuation, Feasibility Studies and Financial Modeling, (2) Corporate Strategy: Strategy Development and Execution, Corporate Performance and Portfolio Management, Business Planning and Budgeting and (3) Governance and Restructuring. In addition to various publications in recognized specialist journals, Mahmoud has many years of experience as a supervisory board member and board committee member.
With over 22 years of professional experience in finance and banking as well as in management positions, Mohammad EsSayed has all the qualifications that FZRO needs for the tasks ahead. Mohammad EsSayed has degrees in finance, including an MBA (Master of Business Administration) in International Corporate Banking, an MFP (Master Financial Professional) and CFA (Certified Financial Analyst) from the USA. FZRO will benefit from his many years of experience as CFO and Managing Director.
Sabrina Godehardt, born on March 16, 1980 in Bad Langensalza, Germany is a certified office communication clerk with over 15 years of experience in medical administration and practice management. She worked as practice manager in a radiology and nuclear medicine clinic from 2015 to 2024, with additional responsibility for IT systems. Since June 2024, she serves as Head of Sales Coordination at CS Diagnostics Pharma GmbH. She holds IHK certifications in practice and marketing management and is proficient in MS Office, Lexware, PACS/RIS systems, and various administrative tools.
Dr. Ralf Herwig is a board-certified physician since 1995 with a doctorate in medicine (magna cum laude) and habilitation in urology. He holds professorial titles and serves as President of both the Austrian Andrological Society and the International Autism Association (2025). His expertise spans urology, andrology, minimally invasive surgery, molecular biology, and sexual medicine, supported by extensive scientific training and over a dozen memberships in international medical societies. He is Editor-in-Chief of multiple scientific journals and has received several prestigious awards for his research.
None
Suite 33, Hill Top Plaza, 13
Gwani Street, Zone 4, Wuse
Abuja 00234
Nigeria
80 Coleman Street
London, ENG W1U 7LP
United Kingdom
801 W. Ann Arbor Trail,
Suite 230 Plymouth,
Plymouth, MI 48170
ISO 13485 and ISO 9001 certified international distribution and development of pharmaceuticals and medical devices.
Headquarters: City of Neuss in Germany City of Bruckmuehl in Germany Dubai, United Arab Emirates